HUC-MSC for Treatment of High-risk HPV Infection

Clinical trial NCT06610773 · RECRUITING

Trial details

NCT number: NCT06610773
Sponsor: Shanghai East Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Human Papillomavirus Viruses Mesenchymal Stem Cells

Start date: 2024-03-01
Primary completion: 2025-09-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.